Biomerica (BMRA) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free BMRA Stock Alerts $0.73 -0.03 (-3.95%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiomerica expands offices, secures new patentsinvesting.com - April 16 at 9:17 PMBiomerica provides update on inFoods® IBS expansionglobenewswire.com - April 15 at 7:47 AMBiomerica (NASDAQ:BMRA) Posts Quarterly Earnings Resultsamericanbankingnews.com - April 15 at 7:08 AMBiomerica GAAP EPS of -$0.11, revenue of $1Mmsn.com - April 15 at 1:29 AMBMRA Stock Earnings: Biomerica Reported Results for Q3 2024investorplace.com - April 13 at 1:08 AMBiomerica Reports Third Quarter 2024 Financial Resultsglobenewswire.com - April 12 at 7:23 PMBiomerica (NASDAQ:BMRA) Stock Price Passes Below Two Hundred Day Moving Average of $0.98americanbankingnews.com - April 9 at 3:36 AMBiomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conferenceglobenewswire.com - March 28 at 8:19 AMBiomerica Inc BMRAmorningstar.com - March 10 at 11:47 AMBiomerica Stock (NASDAQ:BMRA), Short Interest Reportbenzinga.com - February 23 at 7:56 AMDiagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Boardfinance.yahoo.com - February 21 at 10:12 AMDiagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Boardglobenewswire.com - February 21 at 8:19 AMBiomerica Inc.barrons.com - February 20 at 1:54 AMBMRA Mar 2024 2.500 callfinance.yahoo.com - February 17 at 10:10 AMBiomerica Stock (NASDAQ:BMRA) Dividends: History, Yield and Datesbenzinga.com - February 5 at 2:23 PMDiagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomericafinance.yahoo.com - January 23 at 8:45 AMBiomerica Reports Second Quarter 2024 Financial Resultsmarkets.businessinsider.com - January 16 at 1:05 PMIs Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - December 20 at 8:05 AMBiomerica swings 501(k) clearance for H. pylori bacteria diagnostic testmsn.com - December 19 at 3:24 PMNasdaq Gains 100 Points; Biomerica Shares Spike Highermarkets.businessinsider.com - December 18 at 5:53 PMWhy Is Diagnostics Products Focused Biomerica Stock Trading Higher Today?msn.com - December 18 at 12:45 PMBiomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Populationfinance.yahoo.com - December 18 at 12:45 PMBiomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16tmcnet.com - November 10 at 8:48 AMBiomerica Expands inFoods IBS Reach with Addition of Several New GI Groupsfinance.yahoo.com - November 8 at 9:05 AMREPEAT - Biomerica Reports First Quarter 2024 Financial Resultsmarkets.businessinsider.com - October 13 at 4:34 PMBiomerica, Inc.: Biomerica Reports First Quarter 2024 Financial Resultsfinanznachrichten.de - October 13 at 11:34 AMBiomerica Reports First Quarter 2024 Financial Resultsmarkets.businessinsider.com - October 13 at 11:34 AMDubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Testtmcnet.com - September 26 at 9:45 AMDubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Testfinance.yahoo.com - September 26 at 9:45 AMDiagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directorstmcnet.com - August 28 at 9:56 AMBiomerica Full Year 2023 Earnings: US$0.50 loss per share (vs US$0.36 loss in FY 2022)finance.yahoo.com - August 27 at 1:54 PMBiomerica, Inc.: Biomerica Reports Fiscal 2023 Year End Resultsfinanznachrichten.de - August 26 at 7:14 AMBiomerica reports FY resultsmsn.com - August 25 at 9:13 PMBiomerica Reports Fiscal 2023 Year End Resultsfinance.yahoo.com - August 25 at 9:13 PMCVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Testit.tmcnet.com - August 3 at 12:25 PMBiomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patientsfinance.yahoo.com - June 21 at 9:50 AMQRTEA, BIOC and AMTX among mid-day moversseekingalpha.com - May 21 at 11:02 PMinFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technologyit.tmcnet.com - May 18 at 1:07 PMBiomerica, Inc. (BMRA) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - April 17 at 4:28 PMBiomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).finance.yahoo.com - April 17 at 8:54 AMBiomerica, Inc.: Biomerica Reports Q3 Fiscal 2023 Resultsfinanznachrichten.de - April 15 at 10:48 AMBiomerica Reports Q3 Fiscal 2023 Resultsfinance.yahoo.com - April 14 at 6:20 PMBiomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processedfinance.yahoo.com - March 8 at 7:09 PMBiomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stockfinance.yahoo.com - March 7 at 5:12 PMBiomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stockfinance.yahoo.com - March 3 at 5:18 PMBiomerica Announces Proposed Underwritten Public Offering of Common Stockfinance.yahoo.com - March 2 at 7:40 PMWe're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Ratefinance.yahoo.com - February 20 at 10:41 AMBiomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Boardfinance.yahoo.com - January 10 at 8:52 AMBiomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Boardfinance.yahoo.com - January 10 at 8:52 AMBiomerica: H.Pylori Announcements Important To Keep An Eye On, Reaffirm Holdseekingalpha.com - December 24 at 6:43 PM Get Biomerica News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>> BMRA Media Mentions By Week BMRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRA News Sentiment▼-0.020.52▲Average Medical News Sentiment BMRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRA Articles This Week▼70▲BMRA Articles Average Week Get Biomerica News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Trinity Biotech News MyMD Pharmaceuticals News Navidea Biopharmaceuticals News Cardio Diagnostics News OncoCyte News ImmuCell News Aspira Women's Health News ARCA biopharma News Benitec Biopharma News Genetic Technologies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.